Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Wilson

Showing results (351-360 of 657) with videos related to

Pageof 66
Sort By:
Biochemical and Biophysical Research Communications|April 15, 1992
Role of CFTR in lysosome acidificationR W Van Dyke, K V Root, J H Schreiber, et al.
The Journal of Antibiotics|February 1, 1989
9,11-cyclic acetal derivatives of (9S)-9-dihydroerythromycin AE Hunt, D J Knowles, C Shillingford, et al.
Acta Endocrinologica|March 1, 1988
Conventional dose intravenous pulsatile GnRH therapy does not induce ovulation in polycystic ovarian diseaseJ M Wilson, A I Traub, B Sheridan, et al.
The British Journal of Ophthalmology|January 1, 1986
Prediction of amblyopia and squint by means of refraction at age 1 yearR M Ingram, C Walker, J M Wilson, et al.
The Journal of Antibiotics|December 1, 1989
Erythromycin A oxime 11,12-carbonate and its oxime ethersE G Brain, A K Forrest, E Hunt, et al.
Journal of Virology|June 8, 2001
Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transferM Hildinger, A Auricchio, G Gao, et al.
Microbios|January 1, 1993
Polar lipids of strains of Prevotella, Bacteroides and Capnocytophaga analysed by fast atom bombardment mass spectrometryD B Drucker, H S Aluyi, V Boote, et al.
Human Gene Therapy|October 6, 1998
Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouseX Ye, G P Gao, C Pabin, et al.
Molecular Medicine (Cambridge, Mass.)|July 28, 2001
iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophinJ P Louboutin, K Rouger, J M Tinsley, et al.
Texas Heart Institute Journal|February 24, 2001
Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997)P Angelini, W K Vaughn, M Zaqqa, et al.
Pageof 66

Showing results (351-360 of 657) with videos related to

Sort By:
Pageof 66
Biochemical and Biophysical Research Communications|April 15, 1992
Role of CFTR in lysosome acidificationR W Van Dyke, K V Root, J H Schreiber, et al.
The Journal of Antibiotics|February 1, 1989
9,11-cyclic acetal derivatives of (9S)-9-dihydroerythromycin AE Hunt, D J Knowles, C Shillingford, et al.
Acta Endocrinologica|March 1, 1988
Conventional dose intravenous pulsatile GnRH therapy does not induce ovulation in polycystic ovarian diseaseJ M Wilson, A I Traub, B Sheridan, et al.
The British Journal of Ophthalmology|January 1, 1986
Prediction of amblyopia and squint by means of refraction at age 1 yearR M Ingram, C Walker, J M Wilson, et al.
The Journal of Antibiotics|December 1, 1989
Erythromycin A oxime 11,12-carbonate and its oxime ethersE G Brain, A K Forrest, E Hunt, et al.
Journal of Virology|June 8, 2001
Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transferM Hildinger, A Auricchio, G Gao, et al.
Microbios|January 1, 1993
Polar lipids of strains of Prevotella, Bacteroides and Capnocytophaga analysed by fast atom bombardment mass spectrometryD B Drucker, H S Aluyi, V Boote, et al.
Human Gene Therapy|October 6, 1998
Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouseX Ye, G P Gao, C Pabin, et al.
Molecular Medicine (Cambridge, Mass.)|July 28, 2001
iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophinJ P Louboutin, K Rouger, J M Tinsley, et al.
Texas Heart Institute Journal|February 24, 2001
Impact of the "stent-when-feasible" policy on in-hospital and 6-month success and complication rates after coronary angioplasty: single-center experience with 17,956 revascularization procedures (1993-1997)P Angelini, W K Vaughn, M Zaqqa, et al.
Pageof 66